Protecting Free Vaccines Act of 2025 | ChamberLight
Bills · S 2857
IN COMMITTEE· 119TH CONGRESS
Senate BillS 2857Health
Protecting Free Vaccines Act of 2025
INTRO SEP 18· LAST ACTION SEP 18
READING
9MIN
COSPONSORS
2
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
This bill matters because it would remove financial barriers that currently prevent some people from getting recommended vaccines. By making certain immunizations free, it could lead to higher vaccination rates across the country, which helps protect not only individuals but also the wider community from preventable diseases.
If this bill becomes law, people won't have to worry about co-pays or deductibles for specific shots, potentially saving them money and encouraging them to get vaccinated. If it doesn't pass, many people would continue to face out-of-pocket costs for these vaccines, which could deter some from getting them and potentially contribute to lower vaccination rates and a higher risk of disease spread.
KEY PROVISIONS
5AI-extracted
PROVISION 01
Requires private group health plans and individual health insurance coverage to provide full coverage for certain ACIP-recommended immunizations.
This ensures that many working Americans and those with private insurance can access important vaccines without direct cost.
PROVISION 02
Mandates that Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) also cover these specified immunizations without cost-sharing.
This extends free vaccine access to vulnerable populations and those reliant on government health programs.
PROVISION 03
Prohibits any cost-sharing requirements (like co-pays or deductibles) for these covered immunizations.
Eliminating out-of-pocket expenses directly removes a financial barrier to vaccination.
PROVISION 04
Specifies that the covered immunizations are those recommended by ACIP as of October 25, 2024, including updated versions of those vaccines.
This sets a clear baseline for which vaccines must be covered and allows for evolution of vaccine technology.
PROVISION 05
Establishes an effective period for these requirements, generally from the bill's enactment until January 1, 2030 (or December 31, 2029, for Medicaid).
This provision indicates a temporary mandate for free vaccine coverage.
This bill matters because it would remove financial barriers that currently prevent some people from getting recommended vaccines. By making certain immunizations free, it could lead to higher vaccination rates across the country, which helps protect not only individuals but also the wider community from preventable diseases.
If this bill becomes law, people won't have to worry about co-pays or deductibles for specific shots, potentially saving them money and encouraging them to get vaccinated. If it doesn't pass, many people would continue to face out-of-pocket costs for these vaccines, which could deter some from getting them and potentially contribute to lower vaccination rates and a higher risk of disease spread.
KEY PROVISIONS
AI-extracted
high
Requires private group health plans and individual health insurance coverage to provide full coverage for certain ACIP-recommended immunizations.
This ensures that many working Americans and those with private insurance can access important vaccines without direct cost.
high
Mandates that Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) also cover these specified immunizations without cost-sharing.
This extends free vaccine access to vulnerable populations and those reliant on government health programs.
high
Prohibits any cost-sharing requirements (like co-pays or deductibles) for these covered immunizations.
Eliminating out-of-pocket expenses directly removes a financial barrier to vaccination.
med
Specifies that the covered immunizations are those recommended by ACIP as of October 25, 2024, including updated versions of those vaccines.
This sets a clear baseline for which vaccines must be covered and allows for evolution of vaccine technology.
med
Establishes an effective period for these requirements, generally from the bill's enactment until January 1, 2030 (or December 31, 2029, for Medicaid).
This provision indicates a temporary mandate for free vaccine coverage.
Coverage requirements for group health plans and health insurance coverage apply for plan years occurring during or beginning on or after the date of enactment and before January 1, 2030.
Before January 1, 2030
Coverage requirements for Medicare apply for plan years occurring during or beginning on or after the date of enactment and before January 1, 2030.
December 31, 2029
Coverage requirements for Medicaid apply for the period beginning on the date of enactment and ending on December 31, 2029.
October 25, 2024
The covered immunizations are those recommended by ACIP as of this date.
GLOSSARY
AI-written
Immunizations
Vaccinations or shots given to people to protect them from specific diseases.
Advisory Committee on Immunization Practices (ACIP)
A group of medical and public health experts that provides advice and recommendations on vaccine use to the Centers for Disease Control and Prevention (CDC).
Cost-sharing
The portion of healthcare costs that an insured person pays out of their own pocket, such as deductibles, co-payments, and co-insurance.
Group health plan
A health insurance plan offered to employees by an employer or to members by an organization, typically covering multiple people.
Medicare
A federal health insurance program for people 65 or older, certain younger people with disabilities, and people with End-Stage Renal Disease.
Medicaid
A joint federal and state program that helps cover healthcare costs for people with limited income and resources.
Children's Health Insurance Program (CHIP)
A federal and state program that provides low-cost health coverage for children in families who earn too much money to qualify for Medicaid but cannot afford private insurance.
ACTION TIMELINE
2 EVENTS
SEP 18, 25
Introduced in Senate
INTROREFERRAL
SEP 18, 25
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
A medical product like a vaccine, blood product, or gene therapy that is approved by the Food and Drug Administration (FDA) for use in the United States.